Pages that link to "Q43798723"
Jump to navigation
Jump to search
The following pages link to Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes (Q43798723):
Displaying 50 items.
- Cognitive behavioral therapy for substance use disorders (Q22251196) (← links)
- Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview (Q28079382) (← links)
- A Smarter Pathway for Delivering Cue Exposure Therapy? The Design and Development of a Smartphone App Targeting Alcohol Use Disorder. (Q30378639) (← links)
- Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction (Q30478600) (← links)
- Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis (Q30479081) (← links)
- Alcohol use, antiretroviral therapy adherence, and preferences regarding an alcohol-focused adherence intervention in patients with human immunodeficiency virus (Q30575455) (← links)
- Pharmacotherapy of alcohol dependence: a review of the clinical data (Q30936896) (← links)
- Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians (Q33330500) (← links)
- Randomized controlled trial of a mobile phone intervention for improving adherence to naltrexone for alcohol use disorders (Q33443427) (← links)
- A randomized controlled study of exposure therapy as aftercare for alcohol use disorder: study protocol (Q33448355) (← links)
- Using the internet to promote health behavior change: a systematic review and meta-analysis of the impact of theoretical basis, use of behavior change techniques, and mode of delivery on efficacy (Q33720324) (← links)
- The incentive salience of alcohol: translating the effects of genetic variant in CNR1. (Q33797978) (← links)
- Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation (Q33967666) (← links)
- Pharmacoprophylaxis of alcohol dependence: Review and update Part II: Efficacy (Q33974746) (← links)
- Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. (Q34167551) (← links)
- Medical treatment of alcohol dependence: a systematic review (Q34262962) (← links)
- Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? (Q34306652) (← links)
- VIRTUAL REALITY CUE EXPOSURE THERAPY FOR THE TREATMENT OF TOBACCO DEPENDENCE. (Q34377506) (← links)
- Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial (Q34549370) (← links)
- Coping strategy use following computerized cognitive-behavioral therapy for substance use disorders. (Q34689043) (← links)
- The effects of Naltrexone among alcohol non-abstainers: results from the COMBINE Study (Q34689570) (← links)
- A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers (Q34785056) (← links)
- Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study (Q35000244) (← links)
- The alcohol relapse situation appraisal questionnaire: development and validation. (Q35017102) (← links)
- Treatment of late-life depression complicated by alcohol dependence (Q35212161) (← links)
- Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study (Q35622645) (← links)
- Alcohol-cue exposure effects on craving and attentional bias in underage college-student drinkers (Q35637881) (← links)
- Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention (Q35760372) (← links)
- What place does naltrexone have in the treatment of alcoholism? (Q35820303) (← links)
- The nature of coping in treatment for marijuana dependence: latent structure and validation of the Coping Strategies Scale (Q35937085) (← links)
- The opioidergic-alcohol link : implications for treatment (Q36227915) (← links)
- Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers (Q36294656) (← links)
- A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment (Q36364490) (← links)
- Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data (Q36367544) (← links)
- General and religious coping predict drinking outcomes for alcohol dependent adults in treatment (Q36389852) (← links)
- Urge-specific and lifestyle coping strategies of alcoholics: relationships of specific strategies to treatment outcome (Q36420025) (← links)
- Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism (Q36436395) (← links)
- Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention. (Q36461774) (← links)
- Extended-release intramuscular naltrexone (Q36595143) (← links)
- Adoption of Medications in Substance Abuse Treatment: Priorities and Strategies of Single State Authorities (Q36806539) (← links)
- Brief alcohol intervention in the emergency department: moderators of effectiveness (Q36822988) (← links)
- Effects of naltrexone on cortisol levels in heavy drinkers (Q36863387) (← links)
- Effects of a context shift and multiple context extinction on reactivity to alcohol cues (Q36882328) (← links)
- Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (Q36931792) (← links)
- Behavioral characteristics and neurobiological substrates shared by Pavlovian sign-tracking and drug abuse (Q36971332) (← links)
- Effect of naltrexone during extinction of alcohol-reinforced responding and during repeated cue-conditioned reinstatement sessions in a cue exposure style treatment (Q37066471) (← links)
- A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder. (Q37088573) (← links)
- Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. (Q37089324) (← links)
- Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials (Q37227255) (← links)
- A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention (Q37267741) (← links)